Patient Pathfinder: Clinical Trials
Clinical Trials for Chronic Lymphocytic Leukemia
Every life-saving or life-extending treatment that's available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it's approved by the U.S. Food and Drug Administration.
There are 180 active Chronic Lymphocytic Leukemia trials
Tafasitamab, Acalabrutinib, and Obinutuzumab for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
HEALTH4CLL2: A Randomized Waitlist Control Trial of Behavioral Interventions in Patients With Chronic Lymphocytic Leukemia
The Effects of Acute and Chronic Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Biomarker for Infection Risk in CLL and MM
Allo HSCT Using RIC and PTCy for Hematological Diseases
Trial of Anti-CD19 and Anti-CD20 Bicistronic Chimeric Antigen Receptor T Cells for Treating B-Cell Malignancies
There are 180 active Chronic Lymphocytic Leukemia trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.